Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Marriott

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Immunology|September 26, 2002
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cellsJ B Marriott, I A Clarke, K Dredge, et al.
Clinical and Experimental Immunology|December 22, 1999
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitroL La Maestra, A Zaninoni, J B Marriott, et al.
Clinical and Experimental Immunology|October 9, 1998
Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type responseG P Rizzardi, J B Marriott, S Cookson, et al.
Heart (British Cardiac Society)|March 1, 1996
Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relativesJ B Marriott, J H Goldman, P J Keeling, et al.
Immunology Letters|April 15, 1999
The role of HIV gp120 in the disruption of the immune systemA G Dalgleish, J B Marriott, B Souberbielle, et al.
AIDS (London, England)|January 12, 2000
The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed peopleL Brown, B E Souberbielle, J B Marriott, et al.
British Journal of Cancer|October 29, 2002
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effectsK Dredge, J B Marriott, C D Macdonald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha productionJ B Marriott, M Westby, S Cookson, et al.
AIDS (London, England)|July 1, 1996
Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell lineW Barcellini, G P Rizzardi, J B Marriott, et al.
Gene Therapy|October 1, 1996
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccineB E Souberbielle, B C Knight, W J Morrow, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Immunology|September 26, 2002
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cellsJ B Marriott, I A Clarke, K Dredge, et al.
Clinical and Experimental Immunology|December 22, 1999
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitroL La Maestra, A Zaninoni, J B Marriott, et al.
Clinical and Experimental Immunology|October 9, 1998
Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type responseG P Rizzardi, J B Marriott, S Cookson, et al.
Heart (British Cardiac Society)|March 1, 1996
Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relativesJ B Marriott, J H Goldman, P J Keeling, et al.
Immunology Letters|April 15, 1999
The role of HIV gp120 in the disruption of the immune systemA G Dalgleish, J B Marriott, B Souberbielle, et al.
AIDS (London, England)|January 12, 2000
The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed peopleL Brown, B E Souberbielle, J B Marriott, et al.
British Journal of Cancer|October 29, 2002
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effectsK Dredge, J B Marriott, C D Macdonald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha productionJ B Marriott, M Westby, S Cookson, et al.
AIDS (London, England)|July 1, 1996
Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell lineW Barcellini, G P Rizzardi, J B Marriott, et al.
Gene Therapy|October 1, 1996
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccineB E Souberbielle, B C Knight, W J Morrow, et al.
Pageof 3